Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biopure Corp.

www.biopure.com

Latest From Biopure Corp.

Lone Wolfe: Drug Industry Critic Ends Tenure As Advisory Committee Member With Rare Decisive Vote

Sidney Wolfe’s stint as permanent member of the Drug Safety and Risk Management Advisory Committee ended May 31; his final meeting was the May 23 review of Xarelto for ACS. That gave him a second chance to vote against the product. A look back at Wolfe’s tenure shows he was a sure “no” vote when he sat on a panel—but that his service can hardly be construed as having damaged the industry.

BioPharmaceutical Advisory Committees

NormOxys Inc.

The founders of NormOxys are working to commercialize molecules similar to those that give migratory birds the fortitude to fly thousands of miles. When the compound inositol pentaphosphate binds to the protein hemoglobin, its presence helps release up to three of the four oxygen molecules that hemoglobin picks up in the lungs and carries out to the body. NormOxys is betting that its lead candidate can help elevate oxygen levels in human tissues that lack it, and so become a treatment for a range of disorders, from heart failure to diabetic retinopathy, traumatic blood loss, and even cancer.
BioPharmaceutical Platform Technologies

2010 Scrip 100 - Survivors of the shakeout

Crunched credit wiped out many biotech firms in 2009, yet some emerged from the wreckage leaner and stronger. How did they do it, asks Dr Sukaina Virji-Jeganathan.

Metabolic Disorders Cancer

Russian firm to buy troubled Biopure corporation in the US

OPK Biotech, a US subsidiary of the Luxembourg-based OPK Luxadvor owned by Sergei Pugachev, one of Russia's oligarchs, is to acquire the assets of Biopure Corporation, a troubled US biotech company, at a recent bankruptcy court auction in Boston. Biopure filed for chapter 11 bankruptcy protection in the US on July 16th, when its total debt had reached $2.7 million and its assets were worth an estimated $5.1 million.

Luxembourg
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Biopure Corp.
  • Senior Management
  • Zafiris G Zafirelis, Pres. & CEO
    David A Butler, CFO
    Virginia T Rentko, VP, Preclinical Dev.
    Barry Scott, VP, Bus. Dev.
  • Contact Info
  • Biopure Corp.
    Phone: (617) 234-6500
    11 Hurley St.
    Cambridge, MA 02141
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register